Fits the joint model proposed by Henderson and colleagues (2000) 
    <doi:10.1093/biostatistics/1.4.465>, but extended to the case of multiple 
    continuous longitudinal measures. The time-to-event data is modelled using a 
    Cox proportional hazards regression model with time-varying covariates. The 
    multiple longitudinal outcomes are modelled using a multivariate version of the 
    Laird and Ware linear mixed model. The association is captured by a multivariate
    latent Gaussian process. The model is estimated using a Monte Carlo Expectation 
    Maximization algorithm. This project was funded by the Medical Research Council 
    (Grant number MR/M013227/1).

Implements penalised multivariate regression (i.e., for multiple outcomes and many features) by stacked generalisation (<doi:10.1093/bioinformatics/btab576>). For positively correlated outcomes, a single multivariate regression is typically more predictive than multiple univariate regressions. Includes functions for model fitting, extracting coefficients, outcome prediction, and performance measurement. For optional comparisons, install 'remMap' from GitHub (<https://github.com/cran/remMap>).

Provides tools to explore and summarize relationship patterns between
    variables across one or multiple datasets. The package relies on efficient
    sampling strategies to estimate pairwise associations and supports quick
    exploratory data analysis for large or heterogeneous data sources.

Fit survival data and perform dynamic prediction under joint frailty-copula models for tumour progression and death.
 Likelihood-based methods are employed for estimating model parameters, where the baseline hazard functions are modeled by the cubic M-spline or the Weibull model.
 The methods are applicable for meta-analytic data containing individual-patient information from several studies.
 Survival outcomes need information on both terminal event time (e.g., time-to-death) and non-terminal event time (e.g., time-to-tumour progression).
 Methodologies were published in
 Emura et al. (2017) <doi:10.1177/0962280215604510>, Emura et al. (2018) <doi:10.1177/0962280216688032>,
 Emura et al. (2020) <doi:10.1177/0962280219892295>, Shinohara et al. (2020) <doi:10.1080/03610918.2020.1855449>,
 Wu et al. (2020) <doi:10.1007/s00180-020-00977-1>, and Emura et al. (2021) <doi:10.1177/09622802211046390>.
 See also the book of Emura et al. (2019) <doi:10.1007/978-981-13-3516-7>.
 Survival data from ovarian cancer patients are also available.